Preventing cervical cancer - an opportunity for Kenyans

Human papillomavirus vaccine - administration of antigenic material (vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen.

Cervical cancer claims the lives of nine Kenyan women every day and is the leading cause of cancer deaths in women in sub-Saharan Africa. These deaths are tragic, not just because cervical cancer is the most common in women between the ages of 15 to 44, but also because they are almost always preventable through vaccination.